CompoAtlas

Chia & Oat Blend

Natural health product licensed in Canada

Other names
Chang,Qing-Le, Chia-Oat & More
Licence holder
SmartPEP (Canada) Biological Technology Research Ltd.
NPN or DIN-HM
80069263
Status
Active licence
Licence date
9 May 2016
Revision date
Not provided
Form
Sachet
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Avena sativa

Source : Écale de fruit

2 gNot calculated
Avena sativa

Source : Graine(s)

2 gNot calculated
Collagène hydrolysé

Source : Poissons -Peau

Extract : Matériel brut sec

Extraction ratio : 2:1

Dry plant equivalent : 2 g

Potency : 3 % L-lysine

1 gNot calculated
Salvia hispanica

Source : Graine(s)

1.5 gNot calculated
Plantago ovata

Source : Enveloppe

1.25 gNot calculated
Glycine max

Source : Fève de soya

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 0.5 g

Potency : 31.01 % HPLC (22mgAIE)

0.05 gNot calculated
Glycine max

Source : Fève de soya

Potency : 11.1 % HPLC (7.8mg AIE)

Not specifiedNot calculated

Non-medicinal ingredients

Maltodextrine, Sucralose, Konjac

PopulationAgeQuantity per servingFrequency
Femmes ménopausées et en postménopauseNot specified1 Bag2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of non-essential amino acids. Psyllium is used in herbal medicine to promote bowel movements by increasing bulk volume and water content. Source of antioxidant. Soy protein extract helps to attenuate/reduce bone mineral density (BMD) loss in post-menopausal women when used in conjunction with adequate amounts of calcium and vitamin D. Soy protein extract may reduce severe and frequent menopausal symptoms.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80069263

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line